Evance Pakuwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evance Pakuwal has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alice Sarah Day
Basil Hetzel Institute Woodville South South Australia Australia
1 shared publication - Amanda J. Page
Adelaide University
1 shared publication - Andrea Marie Stringer
Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
1 shared publication Andrea Stringer
UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia
1 shared publicationAnna Li
Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia
1 shared publicationBen Forbes
King’s College London, London, UK
1 shared publication
Latest Publications
- Open Access
Translational strategies for oral delivery of faecal microbiota transplantation
Faecal microbiota transplantation (FMT) has emerged as a transformative therapy for Clostridioides difficile infections and shows promise for various GI and systemic diseases. However, the poor patient acceptability and accessibility of ‘conventional’ FMT, typically administered via colonoscopies or enemas, hinders its widespread clinical adoption, particularly for chronic conditions. Oral administration of FMT (OralFMT) overcomes these limitations, yet faces distinct challenges, including a significant capsule burden, palatability concerns and poor microbial viability during gastric transit. This review provides a comprehensive analysis of emerging strategies that aim to advance OralFMT by: (1) refining processing technologies (eg, lyophilisation) that enable manufacturing of low-volume FMT formulations for reducing capsule burden and (2) developing delivery technologies that improve organoleptic acceptability and safeguard the microbiota for targeted colonic release. These advancements present opportunities for OralFMT to expand its therapeutic scope, beyond C. difficile infections, towards chronic GI conditions requiring frequent dosing regimens. While this review primarily focuses on optimising OralFMT delivery, it is important to contextualise these advancements within the broader shift towards defined microbial consortia. Live biotherapeutic products (LBPs) offer an alternative approach, yet the interplay between OralFMT and LBPs in clinical practice remains unresolved. We postulate that continued innovation in OralFMT and LBPs via a multidisciplinary approach can further increase therapeutic efficacy and scalability by enabling disease site targeting, co-delivery of therapeutic compounds and overcoming colonisation resistance. Realising these goals positions OralFMT as a cornerstone of personalised care across a range of diseases rooted in microbiome health.
Open AccessTranslational strategies for oral delivery of faecal microbiota transplantation
Faecal microbiota transplantation (FMT) has emerged as a transformative therapy for Clostridioides difficile infections and shows promise for various GI and systemic diseases. However, the poor patient acceptability and accessibility of ‘conventional’ FMT, typically administered via colonoscopies or enemas, hinders its widespread clinical adoption, particularly for chronic conditions. Oral administration of FMT (OralFMT) overcomes these limitations, yet faces distinct challenges, including a significant capsule burden, palatability concerns and poor microbial viability during gastric transit. This review provides a comprehensive analysis of emerging strategies that aim to advance OralFMT by: (1) refining processing technologies (eg, lyophilisation) that enable manufacturing of low-volume FMT formulations for reducing capsule burden and (2) developing delivery technologies that improve organoleptic acceptability and safeguard the microbiota for targeted colonic release. These advancements present opportunities for OralFMT to expand its therapeutic scope, beyond C. difficile infections, towards chronic GI conditions requiring frequent dosing regimens. While this review primarily focuses on optimising OralFMT delivery, it is important to contextualise these advancements within the broader shift towards defined microbial consortia. Live biotherapeutic products (LBPs) offer an alternative approach, yet the interplay between OralFMT and LBPs in clinical practice remains unresolved. We postulate that continued innovation in OralFMT and LBPs via a multidisciplinary approach can further increase therapeutic efficacy and scalability by enabling disease site targeting, co-delivery of therapeutic compounds and overcoming colonisation resistance. Realising these goals positions OralFMT as a cornerstone of personalised care across a range of diseases rooted in microbiome health.
- 16 September 2024
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The Efficacy of Microbiome-Targeted Therapy in Modulating Gut Health in Alcohol-Induced Liver Injury: A Systematic Review and Meta-Analysis
INPLASY202490059 The Efficacy of Microbiome-Targeted Therapy in Modulating Gut Health in Alcohol-Induced Liver Injury: A Systematic Review and Meta-Analysis Keywords: gut microbiome; microbiome tar…
- 16 September 2024
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The Efficacy of Microbiome-Targeted Therapy in Modulating Gut Health in Alcohol-Induced Liver Injury: A Systematic Review and Meta-Analysis
INPLASY202490059 The Efficacy of Microbiome-Targeted Therapy in Modulating Gut Health in Alcohol-Induced Liver Injury: A Systematic Review and Meta-Analysis Keywords: gut microbiome; microbiome tar…
- Open Access
- 31 July 2021
- Published by Biotechnology Society of Nepal in Nepal Journal of Biotechnology
- Vol. 9 (1) , 42-49
Comparative Study of Nutritional Profile of Rice Varieties in Nepal
The purpose of this study was to evaluate and compare the nutritional quality of different rice varieties (Taichung-176, Khumal-4 rice, and Black rice) with Jumli Marsi rice. The highest nutritional factors and phytochemical components were found in the Marsi rice (RR) and Black rice (BR). The highest amount of antioxidant property and phenolic content was found in Black rice which was 61.58 ± 0.02% and 22.75 ± 0.02GAE/100g respectively. The reducing sugar was found to be highest in the TR rice variety, which was 2.74±0.01%. The results also highlight the cooking and physicochemical properties of rice depending on the amylose content of rice varieties. The qualitative analysis of the phytochemical content in different rice varieties showed the presence of tannin, flavonoid, alkaloid, and terpenoid in Marsi and BR. While anthraquinone and saponin were negative for all the rice varieties, protein and glycoside were found to be present in all the rice varieties. Also, the pigmented rice varieties were found to have high nutritional components compared to the non-pigmented rice varieties. All the data observed in the study was found to be statistically significant (p < 0.05).
- 31 July 2021
- Published by Biotechnology Society of Nepal in Nepal Journal of Biotechnology
- Vol. 9 (1) , 42-49
Open AccessComparative Study of Nutritional Profile of Rice Varieties in Nepal
The purpose of this study was to evaluate and compare the nutritional quality of different rice varieties (Taichung-176, Khumal-4 rice, and Black rice) with Jumli Marsi rice. The highest nutritional factors and phytochemical components were found in the Marsi rice (RR) and Black rice (BR). The highest amount of antioxidant property and phenolic content was found in Black rice which was 61.58 ± 0.02% and 22.75 ± 0.02GAE/100g respectively. The reducing sugar was found to be highest in the TR rice variety, which was 2.74±0.01%. The results also highlight the cooking and physicochemical properties of rice depending on the amylose content of rice varieties. The qualitative analysis of the phytochemical content in different rice varieties showed the presence of tannin, flavonoid, alkaloid, and terpenoid in Marsi and BR. While anthraquinone and saponin were negative for all the rice varieties, protein and glycoside were found to be present in all the rice varieties. Also, the pigmented rice varieties were found to have high nutritional components compared to the non-pigmented rice varieties. All the data observed in the study was found to be statistically significant (p < 0.05).